Sabra Healthcare SBRA Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $196.63M+5.2% | $187M+5.1% | $177.9M+3.4% | $172.11M+1.1% | $170.2M+0.3% | ||
| $11.75M+3.4% | $11.36M+4.9% | $10.83M+2.7% | $10.54M+14.9% | $9.18M+2.1% | ||
| $366.71M+5.2% | $348.61M+2.2% | $341.15M+0.7% | $338.84M+0.2% | $338.01M+8.8% | ||
| -$466.61M-23.5% | -$377.96M— | —— | —— | —— | ||
| $293.78M+1.5% | $289.5M+1.3% | $285.67M+0.6% | $284.01M+0.7% | $282.08M+0.7% | ||
| —— | —— | —— | —— | -$262.57M-44.6% | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Sabra Healthcare's cash flow data come from?
- Every line is extracted from Sabra Healthcare's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.